report News - The Latest News, Insight, Commentary & Analysis at Healthcare Asia Magazine

report

Self-service kiosks for healthcare market to reach $3.77b by 2034

There is a growing adoption in hospitals, clinics, and pharmacies.

Global ophthalmology drugs market to hit $26.28b by 2030

Investments, strategic collaborations, and therapy advancements drive growth.

7MM multiple sclerosis-diagnosed cases to reach 1.64 million by 2033

Japan is expected to have the lowest count at 31,527 cases.

APAC eyes fastest growth in global cardiovascular information system market

Thanks to rapid urbanisation and increased healthcare spending.

Global cancer immunotherapy market to be valued at $247.2b by 2029

Developments in genomics, AI, and biotechnology are driving market growth.

Australia’s nuclear imaging agents market to hit $30m by 2036

Its growth is driven by a rise in prostate cancer cases.

Liver disease treatment market to be valued at $69.1b by 2030

Personalised medicine and fibrosis-targeting treatments are key growth areas.

Japan’s cardiac marker test market to reach $19m by 2036

The country accounted for 20% of the Asia-Pacific market in 2024.

Indonesian hospital revenues may drop up to 6% in FY26: report

The fall is attributed to an anticipated 10% drop in private-insured patient volumes.

APAC to see fastest growth in global care management solutions market

China, India, and Japan are investing heavily in healthcare IT infrastructure.

Global HLA typing market to hit $1.7b by 2030

Increased investments in transplantation are driving growth.

7MM PAH diagnosed cases to fall to 76,035 by 2034

The projection represents a negative annual growth rate of 0.08%.

7MM sarcopenia market to see 8.1% CAGR growth until 2034

There are currently no approved drugs to treat the condition.

Digital assistants in healthcare market to hit $1.5b by 2030

Thanks to the rising demand for scalable patient engagement solutions.

India’s dialysis machines market eyes 2% CAGR growth until 2036

It accounted for around 3% of the Asia-Pacific market in 2024.